Free Trial
NASDAQ:TBIO

Telesis Bio (TBIO) Stock Price, News & Analysis

Telesis Bio logo
$0.01 0.00 (-9.76%)
As of 09/26/2025 02:14 PM Eastern

About Telesis Bio Stock (NASDAQ:TBIO)

Advanced

Key Stats

Today's Range
$0.0111
$0.0111
50-Day Range
$0.00
$0.02
52-Week Range
$0.00
$3.95
Volume
122 shs
Average Volume
5,773 shs
Market Capitalization
$20.00 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Telesis Bio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TBIO Stock News Headlines

A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
Telesis Bio Announces Departure of Chief Legal Officer
See More Headlines

TBIO Stock Analysis - Frequently Asked Questions

Telesis Bio's stock was trading at $0.40 at the beginning of 2025. Since then, TBIO shares have decreased by 97.2% and is now trading at $0.0111.

Telesis Bio, Inc. (NASDAQ:TBIO) released its quarterly earnings data on Monday, November, 8th. The company reported ($6.12) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($5.04) by $1.08. The business had revenue of $2.79 million for the quarter, compared to the consensus estimate of $2.93 million.

Shares of Telesis Bio reverse split on Thursday, May 9th 2024.The 1-18 reverse split was announced on Thursday, May 9th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 9th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Telesis Bio (TBIO) raised $100 million in an initial public offering on Thursday, June 28th 2018. The company issued 7,700,000 shares at $12.00-$14.00 per share. Citigroup, Leerink Partners and Evercore ISI acted as the underwriters for the IPO.

Shares of TBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Telesis Bio investors own include Ford Motor (F), Pfizer (PFE), PayPal (PYPL), SoFi Technologies (SOFI), Plug Power (PLUG) and XPeng (XPEV).

Company Calendar

Last Earnings
11/08/2021
Today
9/27/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:TBIO
Previous Symbol
NASDAQ:DNAY
CIK
1850079
Fax
N/A
Employees
200
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
($28.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.72 million
Net Margins
-336.59%
Pretax Margin
-334.81%
Return on Equity
N/A
Return on Assets
-61.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.23
Quick Ratio
1.06

Sales & Book Value

Annual Sales
$225.09 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.14 per share
Price / Book
0.08

Miscellaneous

Outstanding Shares
1,802,000
Free Float
1,360,000
Market Cap
$20.00 thousand
Optionable
Optionable
Beta
2.73

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:TBIO) was last updated on 9/27/2025 by MarketBeat.com Staff
From Our Partners